| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.06. | Owlet (OWLT) Moves 7.3% Higher: Will This Strength Last? | 2 | Zacks | ||
| 05.06. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.05. | Here's Why Owlet (OWLT) Crashed 60% in Q1 | 7 | Insider Monkey | ||
| 11.05. | Owlet, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| OWLET Aktie jetzt für 0€ handeln | |||||
| 11.05. | Owlet, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Owlet, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 06.04. | Führungswechsel bei Owlet: CEO Jonathan Harris tritt zurück, Gründer Kurt Workman übernimmt | 2 | Investing.com Deutsch | ||
| 06.04. | Owlet CEO Jonathan Harris resigns, founder Kurt Workman returns | 1 | Investing.com | ||
| 06.04. | Owlet, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.03. | Owlet, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 09.03. | Owlet, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 09.03. | Why Is Owlet Stock Falling Monday? | 2 | Benzinga.com | ||
| 06.03. | TD Cowen lowers Owlet stock price target to $13 on Q1 guidance | 1 | Investing.com | ||
| 06.03. | Owlet's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y | 2 | Zacks | ||
| 06.03. | Northland cuts Owlet stock price target to $15 on guidance | 2 | Investing.com | ||
| 06.03. | Owlet stock dips as investors assess softer-than-expected first-quarter guidance | 2 | Seeking Alpha | ||
| 06.03. | Owlet outlines 19%-23% revenue growth target for 2026 while expanding AI, telehealth, and international markets | 2 | Seeking Alpha | ||
| 05.03. | Owlet Q4 2025: Rekordumsatzwachstum trotz Zollbelastungen | - | Investing.com Deutsch | ||
| 05.03. | Owlet Q4 2025 slides: record revenue growth amid tariff pressures | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 1,450 | 0,00 % | -17,58% Rückgang bei BICO: Analyse der Preisveränderung | ||
| PLUS THERAPEUTICS | 3,650 | +2,53 % | Plus Therapeutics wins Elevance Health coverage deal | ||
| ORGANON | 11,805 | -0,38 % | Organon and Henlius launch Prolia and Xgeva biosimilars in Canada | ||
| QUIDELORTHO | 12,100 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 1,100 | +0,92 % | Nano-X tumbles after Q1 revenue miss, going concern risks | ||
| ROCKWELL MEDICAL | 0,605 | +4,31 % | ROCKWELL MEDICAL, INC. - 8-K, Current Report | ||
| NUWELLIS, INC | 3,250 | -1,52 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA92838G1090 Visionary Metals Corp. 25.06.2026 CA92838G2080 Visionary Metals Corp. 26.06.2026 Tausch 4:1US67113Y7022 Nuwellis... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,560 | 0,00 % | Evercore ISI initiates Procept BioRobotics stock with outperform rating | ||
| NEURONETICS | 1,090 | -8,02 % | Neuronetics, Inc. - 8-K, Current Report | ||
| PULSE BIOSCIENCES | 25,000 | +0,81 % | Pulse Biosciences, Inc.: Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse Cardiac Catheter System for Atrial Fibrillation | U.S. IDE Enrollment follows groundbreaking 96% procedural success at 12 months in European feasibility study Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary... ► Artikel lesen | |
| PROGYNY | 28,510 | 0,00 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| OPTIMIZERX | 5,120 | 0,00 % | OptimizeRx Corporation: OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms | ||
| PAVMED | 3,655 | -7,47 % | PAVmed Inc. - 8-K, Current Report | ||
| ORTHOFIX MEDICAL | 7,900 | 0,00 % | Orthofix Medical Inc. - 8-K, Current Report | ||
| QTREX QUANTUM | 1,600 | -0,62 % | QTREX announces management plan to purchase up to 2M shares |